Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2021-04-13
DOI
10.1080/14787210.2021.1912593
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study
- (2021) Khadijeh Ahmadi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action
- (2021) M. De Angelis et al. FASEB JOURNAL
- Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
- (2020) Shuai Xia et al. Cellular & Molecular Immunology
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
- (2020) Jared S. Morse et al. CHEMBIOCHEM
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses
- (2020) Jieliang Chen MICROBES AND INFECTION
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Puzzle of highly pathogenic human coronaviruses (2019-nCoV)
- (2020) Jing Li et al. Protein & Cell
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
- (2020) Shivraj Hariram Nile et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity
- (2020) Yuanmei Zhu et al. JOURNAL OF VIROLOGY
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
- (2020) Paolo Calligari et al. Viruses-Basel
- The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria
- (2020) Douglas B. Kell et al. Frontiers in Immunology
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Molecular immune pathogenesis and diagnosis of COVID-19
- (2020) Xiaowei Li et al. Journal of Pharmaceutical Analysis
- Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37
- (2020) Mardi A. Crane-Godreau et al. Frontiers in Public Health
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Identification of potential binders of the main protease 3CLpro of the COVID-19 via structure-based ligand design and molecular modeling
- (2020) Marina Macchiagodena et al. CHEMICAL PHYSICS LETTERS
- Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics
- (2020) Sonya VanPatten et al. Future Medicinal Chemistry
- Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
- (2020) Elena Campione et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bee venom and SARS-CoV-2
- (2020) Wei Yang et al. TOXICON
- Three kinds of treatment with Homoharringtonine, Hydroxychloroquine or shRNA and their combination against coronavirus PEDV in vitro
- (2020) Cui-Cui Li et al. Virology Journal
- Emerging Therapeutic Modalities against COVID-19
- (2020) Shipra Malik et al. Pharmaceuticals
- COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein
- (2020) Sepehr Ehsani Biology Direct
- Repurposing anticancer drugs for the management of COVID-19
- (2020) Khalid El Bairi et al. EUROPEAN JOURNAL OF CANCER
- Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
- (2020) Yuchen Huan et al. Frontiers in Microbiology
- Targeting complement cascade: an alternative strategy for COVID-19
- (2020) Sureshbabu Ram Kumar Pandian et al. 3 Biotech
- Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
- (2020) Bapi Pahar et al. Vaccines
- FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
- (2020) Sylwester Drożdżal et al. DRUG RESISTANCE UPDATES
- In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2
- (2020) Yamil Liscano et al. MOLECULES
- Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins
- (2019) Arianna Sala et al. INTERVIROLOGY
- Bovine Lactoferrin Prevents Influenza A Virus Infection by Interfering with the Fusogenic Function of Viral Hemagglutinin
- (2019) Fabiana Superti et al. Viruses-Basel
- Peptidomimetics: A Synthetic Tool for Inhibiting Protein–Protein Interactions in Cancer
- (2019) Lloyd Mabonga et al. International Journal of Peptide Research and Therapeutics
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- Envelope-deforming antiviral peptide derived from influenza virus M2 protein
- (2019) Younghun Jung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antiviral peptides as promising therapeutic drugs
- (2019) Liana Costa Pereira Vilas Boas et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Human Antimicrobial Peptides as Therapeutics for Viral Infections
- (2019) Aslaa Ahmed et al. Viruses-Basel
- A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of HIV-1, HIV-2, and Simian Immunodeficiency Virus
- (2019) Xiaoran Tang et al. JOURNAL OF VIROLOGY
- Insilico Alpha-Helical Structural Recognition of Temporin Antimicrobial Peptides and Its Interactions with Middle East Respiratory Syndrome-Coronavirus
- (2019) Sathish Kumar Marimuthu et al. International Journal of Peptide Research and Therapeutics
- A Novel Chimeric Anti-HCV Peptide Derived from Camel Lactoferrin and Molecular Level Insight on Its Interaction with E2
- (2019) Mojtaba Tahmoorespur et al. International Journal of Peptide Research and Therapeutics
- The Amphibian Antimicrobial Peptide Temporin B Inhibits In Vitro Herpes Simplex Virus 1 Infection
- (2018) M. E. Marcocci et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan – How to Do it Yourself!
- (2018) Samuel J.S. Rubin et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Human β-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity
- (2018) Ju Kim et al. Virology Journal
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Antiviral activity of animal venom peptides and related compounds
- (2017) Élida Cleyse Gomes da Mata et al. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
- In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2
- (2017) K. Alagarasu et al. PEPTIDES
- Lipidation increases antiviral activities of coronavirus fusion-inhibiting peptides
- (2017) Jung-Eun Park et al. VIROLOGY
- Defensins in Viral Infection and Pathogenesis
- (2017) Mayumi K. Holly et al. Annual Review of Virology
- The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
- (2017) Kornelius Zeth et al. Frontiers in Chemistry
- Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus
- (2016) Takuya Matsumura et al. HEPATOLOGY RESEARCH
- Apitherapy Products for Medicinal Use
- (2016) Patrick M. Fratellone et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans
- (2016) Silke M. Currie et al. JOURNAL OF IMMUNOLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
- (2016) Hanjun Zhao et al. Scientific Reports
- Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections
- (2016) Fern Findlay et al. Pathogens and Global Health
- Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
- (2016) Margit Mahlapuu et al. Frontiers in Cellular and Infection Microbiology
- Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
- (2016) Jonathan Shuter Therapeutics and Clinical Risk Management
- Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived PeptideIn VitroandIn VivoTo Reduce Replication and Pathogenesis
- (2015) Yi Wang et al. JOURNAL OF VIROLOGY
- Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care
- (2015) Timo Wolf et al. LANCET
- Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses
- (2015) Shweta Tripathi et al. PLoS One
- Perspective of Use of Antiviral Peptides against Influenza Virus
- (2015) Sylvie Skalickova et al. Viruses-Basel
- Short Peptide Type I Interferon Mimetics: Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections
- (2014) Chulbul M. Ahmed et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Alpha-Defensin HD5 Inhibits Furin Cleavage of Human Papillomavirus 16 L2 To Block Infection
- (2014) Mayim E. Wiens et al. JOURNAL OF VIROLOGY
- Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
- (2014) Shuai Xia et al. VIRUS RESEARCH
- Delineation of Interfaces on Human Alpha-Defensins Critical for Human Adenovirus and Human Papillomavirus Inhibition
- (2014) Victoria R. Tenge et al. PLoS Pathogens
- Cationic Host Defence Peptides: Potential as Antiviral Therapeutics
- (2013) Emily Gwyer Findlay et al. BIODRUGS
- Antiviral potential of cathelicidins
- (2013) Peter G Barlow et al. Future Microbiology
- Analysis and Prediction of Highly Effective Antiviral Peptides Based on Random Forests
- (2013) Kuan Y. Chang et al. PLoS One
- Multiple Membrane Interactions and Versatile Vesicle Deformations Elicited by Melittin
- (2013) Tomoyoshi Takahashi et al. Toxins
- Enhancement of Antiviral Activity of Human Alpha-Defensin 5 against Herpes Simplex Virus 2 by Arginine Mutagenesis at Adaptive Evolution Sites
- (2012) A. Wang et al. JOURNAL OF VIROLOGY
- Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
- (2012) Y. Kim et al. JOURNAL OF VIROLOGY
- Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus
- (2012) P. C. Y. Woo et al. JOURNAL OF VIROLOGY
- AVPpred: collection and prediction of highly effective antiviral peptides
- (2012) Nishant Thakur et al. NUCLEIC ACIDS RESEARCH
- Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus
- (2012) Hongyan Liu et al. PLoS One
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
- (2012) Sandrine Belouzard et al. Viruses-Basel
- Multiple Immune-Modulatory Functions Of Cathelicidin Host Defense Peptides
- (2012) Ka-Yee (Grace) Choi et al. Frontiers in Immunology
- Inhibition of HIV-1 Integration in Ex Vivo-Infected CD4 T Cells from Elite Controllers
- (2011) M. J. Buzon et al. JOURNAL OF VIROLOGY
- Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses
- (2011) Qiaoli Li et al. PEPTIDES
- Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37
- (2011) Peter G. Barlow et al. PLoS One
- Review: Defensins and cathelicidins in lung immunity
- (2010) Tesfaldet Tecle et al. Innate Immunity
- Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy
- (2010) Teruhiko Matsubara et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics
- (2010) Chungen Pan et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Defensins in Viral Infections
- (2009) Jian Ding et al. Journal of Innate Immunity
- Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease
- (2009) C. L. Wohlford-Lenane et al. JOURNAL OF VIROLOGY
- Antimicrobial Peptides as Model Molecules for the Development of Novel Antiviral Agents in Aquaculture
- (2009) A. Falco et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Mucroporin, the First Cationic Host Defense Peptide from the Venom of Lychas mucronatus
- (2008) C. Dai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Innate immunity to influenza virus: implications for future therapy
- (2008) Mitchell R White et al. Expert Review of Clinical Immunology
- Role of Human β-Defensin-2 during Tumor Necrosis Factor-α/NF-κB-mediated Innate Antiviral Response against Human Respiratory Syncytial Virus
- (2008) Srikanth Kota et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started